Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)
This study has been completed.
Study NCT00795522 Information provided by Merck Sharp & Dohme Corp.
First Received on November 19, 2008. Last Updated on April 20, 2015
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Immune System Diseases
Skin Diseases, Vascular
Interventions listed in this trial
More general drug interventions related to this trial
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers